Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
US7112595B2 · kind B2 · utility
63Cited by
8References
23Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 3, 2003 |
| Grant date | Sep 26, 2006 |
| Priority date | — |
| Expiry date | Feb 4, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides compounds and pharmaceutical compositions that act as antagonists at metabotropic glutamate receptors, and that are useful for treating neurological diseases and disorders. Methods of preparing the compounds also are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.